This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Otmar Herrgott - Innovator in Cancer Treatment
Introduction
Otmar Herrgott is a notable legal representative and inventor based in Freiburg, Germany. He has made significant contributions to the field of cancer treatment through his innovative patent. His work focuses on improving the effectiveness of chemotherapy for lung cancer patients.
Latest Patents
Otmar Herrgott holds a patent for a method that determines whether a biological sample comprising human lung cancer cells is sensitive to a combination of an epidermal growth factor receptor inhibitor and a chemotherapeutic agent. This invention involves assessing the overexpression of phosphorylated AKT protein and/or phosphorylated MAPK protein in the biological sample. The patent also includes methods for deriving candidate agents or selecting compositions aimed at inhibiting the progression of lung cancer in patients.
Career Highlights
Otmar Herrgott has established himself as a key figure in the medical and legal fields. His expertise as a legal representative complements his innovative work in cancer research. He is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry.
Collaborations
Otmar collaborates with talented professionals in his field, including Verena Lutz and Astrid Heller. Their combined efforts contribute to advancing cancer treatment methodologies.
Conclusion
Otmar Herrgott's contributions to cancer treatment through his patent demonstrate his commitment to improving patient outcomes. His work exemplifies the intersection of innovation and legal expertise in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
